1. Home
  2. CTMX vs SHBI Comparison

CTMX vs SHBI Comparison

Compare CTMX & SHBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$4.39

Market Cap

596.2M

Sector

Health Care

ML Signal

HOLD

Logo Shore Bancshares Inc

SHBI

Shore Bancshares Inc

HOLD

Current Price

$17.97

Market Cap

618.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTMX
SHBI
Founded
2008
1876
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
596.2M
618.4M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
CTMX
SHBI
Price
$4.39
$17.97
Analyst Decision
Strong Buy
Buy
Analyst Count
6
2
Target Price
$6.50
$18.75
AVG Volume (30 Days)
2.8M
182.2K
Earning Date
11-06-2025
01-29-2026
Dividend Yield
N/A
2.68%
EPS Growth
50.22
38.21
EPS
0.24
1.71
Revenue
$113,631,000.00
$212,493,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$13.77
P/E Ratio
$18.32
$10.52
Revenue Growth
N/A
10.07
52 Week Low
$0.40
$11.47
52 Week High
$4.62
$19.22

Technical Indicators

Market Signals
Indicator
CTMX
SHBI
Relative Strength Index (RSI) 61.95 54.38
Support Level $3.86 $17.31
Resistance Level $4.37 $18.99
Average True Range (ATR) 0.26 0.45
MACD 0.02 -0.12
Stochastic Oscillator 90.71 35.08

Price Performance

Historical Comparison
CTMX
SHBI

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About SHBI Shore Bancshares Inc

Shore Bancshares Inc is a financial holding company. It offers personalized banking, insurance, and investment services to families and businesses in the Mid-Atlantic region. It operates in one business segment- banking. The company's primary source of revenue is derived from interest earned on commercial, residential mortgage and other loans, and fees charged in connection with lending and other banking services located in Maryland, Delaware and Virginia.

Share on Social Networks: